
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Anti-SARS-CoV-2 IgG and IgA antibodies in COVID-19 convalescent plasma do not enhance viral infection
Natasha M. Clark, Sanath Kumar Janaka, William R. Hartman, et al.
PLoS ONE (2022) Vol. 17, Iss. 3, pp. e0257930-e0257930
Open Access | Times Cited: 15
Natasha M. Clark, Sanath Kumar Janaka, William R. Hartman, et al.
PLoS ONE (2022) Vol. 17, Iss. 3, pp. e0257930-e0257930
Open Access | Times Cited: 15
Showing 15 citing articles:
Role of the humoral immune response during COVID-19: guilty or not guilty?
Melyssa Yaugel-Novoa, Thomas Bourlet, Stéphane Paul
Mucosal Immunology (2022) Vol. 15, Iss. 6, pp. 1170-1180
Open Access | Times Cited: 38
Melyssa Yaugel-Novoa, Thomas Bourlet, Stéphane Paul
Mucosal Immunology (2022) Vol. 15, Iss. 6, pp. 1170-1180
Open Access | Times Cited: 38
Convalescent plasma therapy in COVID-19: Unravelling the data using the principles of antibody therapy
Arturo Casadevall, Michael J. Joyner, Liise-anne Pirofski, et al.
Expert Review of Respiratory Medicine (2023) Vol. 17, Iss. 5, pp. 381-395
Closed Access | Times Cited: 25
Arturo Casadevall, Michael J. Joyner, Liise-anne Pirofski, et al.
Expert Review of Respiratory Medicine (2023) Vol. 17, Iss. 5, pp. 381-395
Closed Access | Times Cited: 25
Immunoglobulin A response to SARS-CoV-2 infection and immunity
Khaleqsefat Esmat, Baban Jamil, Ramiar Kamal Kheder, et al.
Heliyon (2024) Vol. 10, Iss. 1, pp. e24031-e24031
Open Access | Times Cited: 5
Khaleqsefat Esmat, Baban Jamil, Ramiar Kamal Kheder, et al.
Heliyon (2024) Vol. 10, Iss. 1, pp. e24031-e24031
Open Access | Times Cited: 5
Immunogenicity and immune-persistence of the CoronaVac or Covilo inactivated COVID-19 Vaccine: a 6-month population-based cohort study
Qianhui Hua, Hangjie Zhang, Pingping Yao, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 19
Qianhui Hua, Hangjie Zhang, Pingping Yao, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 19
Structural Dynamics of the SARS-CoV-2 Spike Protein: A 2-Year Retrospective Analysis of SARS-CoV-2 Variants (from Alpha to Omicron) Reveals an Early Divergence between Conserved and Variable Epitopes
Patrick M. Guérin, Nouara Yahi, Fodil Azzaz, et al.
Molecules (2022) Vol. 27, Iss. 12, pp. 3851-3851
Open Access | Times Cited: 14
Patrick M. Guérin, Nouara Yahi, Fodil Azzaz, et al.
Molecules (2022) Vol. 27, Iss. 12, pp. 3851-3851
Open Access | Times Cited: 14
Effectiveness of COVID-19 Convalescent Plasma (CCP) During the Pandemic Era: A Literature Review
Usha Rani Kandula, Techane Sisay Tuji, Dinkinesh Begna Gudeta, et al.
Journal of Blood Medicine (2023) Vol. Volume 14, pp. 159-187
Open Access | Times Cited: 7
Usha Rani Kandula, Techane Sisay Tuji, Dinkinesh Begna Gudeta, et al.
Journal of Blood Medicine (2023) Vol. Volume 14, pp. 159-187
Open Access | Times Cited: 7
Transfusion reactions associated with COVID ‐19 convalescent plasma in outpatient clinical trials
Moisés A. Huamán, Jay S. Raval, James H. Paxton, et al.
Transfusion (2023) Vol. 63, Iss. 9, pp. 1639-1648
Open Access | Times Cited: 7
Moisés A. Huamán, Jay S. Raval, James H. Paxton, et al.
Transfusion (2023) Vol. 63, Iss. 9, pp. 1639-1648
Open Access | Times Cited: 7
Prior COVID-19 Immunization Does Not Cause IgA- or IgG-Dependent Enhancement of SARS-CoV-2 Infection
Melyssa Yaugel-Novoa, Blandine Noailly, Fabienne Jospin, et al.
Vaccines (2023) Vol. 11, Iss. 4, pp. 773-773
Open Access | Times Cited: 4
Melyssa Yaugel-Novoa, Blandine Noailly, Fabienne Jospin, et al.
Vaccines (2023) Vol. 11, Iss. 4, pp. 773-773
Open Access | Times Cited: 4
Current and emerging immunomodulators for treatment of SARS-CoV2 infection (COVID-19)
Matthew W. McCarthy
Expert Opinion on Pharmacotherapy (2022) Vol. 23, Iss. 5, pp. 623-628
Open Access | Times Cited: 7
Matthew W. McCarthy
Expert Opinion on Pharmacotherapy (2022) Vol. 23, Iss. 5, pp. 623-628
Open Access | Times Cited: 7
Post-vaccination SARS-CoV-2 seroprevalence in children aged 3-11 years and the positivity in unvaccinated children: A retrospective, single-center study
Jing Li, Menglei Ge, Shuzhi Dai, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 6
Jing Li, Menglei Ge, Shuzhi Dai, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 6
Seroprevalence of immunoglobulin G antibodies against SARS-CoV-2 in Cyprus
Christos Papaneophytou, Andria Nicolaou, Myrtani Pieri, et al.
PLoS ONE (2022) Vol. 17, Iss. 6, pp. e0269885-e0269885
Open Access | Times Cited: 4
Christos Papaneophytou, Andria Nicolaou, Myrtani Pieri, et al.
PLoS ONE (2022) Vol. 17, Iss. 6, pp. e0269885-e0269885
Open Access | Times Cited: 4
Comparative Analysis of Vaccine-induced Immunity and Natural Immunity in Post-COVID Patients
Saulesh Kurmangalieva, Akzhan M. Madenbayeva, Saltanat T. Urazayeva, et al.
West Kazakhstan Medical Journal (2024) Vol. 66, Iss. 4, pp. 387-400
Open Access
Saulesh Kurmangalieva, Akzhan M. Madenbayeva, Saltanat T. Urazayeva, et al.
West Kazakhstan Medical Journal (2024) Vol. 66, Iss. 4, pp. 387-400
Open Access
Theoretical Explanation for the Rarity of Antibody-Dependent Enhancement of Infection (ADE) in COVID-19
Anna E. Boldova, Julia-Jessica D. Korobkin, Yury D. Nechipurenko, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 19, pp. 11364-11364
Open Access | Times Cited: 3
Anna E. Boldova, Julia-Jessica D. Korobkin, Yury D. Nechipurenko, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 19, pp. 11364-11364
Open Access | Times Cited: 3
Pathways to altered virulence of SARS-CoV-2
Laura F. White, Debra Van Egeren, Madison Stoddard, et al.
(2023)
Closed Access | Times Cited: 1
Laura F. White, Debra Van Egeren, Madison Stoddard, et al.
(2023)
Closed Access | Times Cited: 1
Lessons learned from the use of COVID-19 convalescent plasma at Kaiser Permanente
Kevin Tse, Qiaoling Chen, Ariadna Padilla, et al.
Journal of Allergy and Clinical Immunology Global (2022) Vol. 1, Iss. 4, pp. 309-311
Open Access
Kevin Tse, Qiaoling Chen, Ariadna Padilla, et al.
Journal of Allergy and Clinical Immunology Global (2022) Vol. 1, Iss. 4, pp. 309-311
Open Access